“Infection” Named Primary Cause of Nonrelapse Death in CAR T Therapy Study
LOS ANGELES, California – A recent study has revealed that infection is the leading cause of nonrelapse death among patients undergoing CAR T cell therapy for cancer. CAR T cell therapy is a type of immunotherapy that involves reprogramming a patient’s T cells to target cancer cells. The research, conducted by a team at the University of California, Los Angeles, examined the factors contributing to nonrelapse mortality in patients undergoing this innovative treatment. The study, …